Apple (NASDAQ:AAPL – Get Rating) was downgraded by DA Davidson from a “buy” rating to a “neutral” rating in a report released on Monday, The Fly reports. A number of other equities research analysts also recently issued reports on AAPL. 58.com reissued a “maintains” rating on shares of Apple in a report on Monday. Evercore […]
Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Rating) have been assigned an average rating of “Moderate Buy” from the thirteen brokerages that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) rose 3.7% during mid-day trading on Wednesday . The company traded as high as $21.49 and last traded at $21.41. Approximately 793,171 shares were traded during mid-day trading, a decline of 78% from the average daily volume of 3,674,765 shares. The stock had previously closed at $20.64. Wall […]
Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Rating) traded down 3% on Monday . The stock traded as low as $26.71 and last traded at $26.73. 324,149 shares traded hands during mid-day trading, an increase of 29% from the average session volume of 251,680 shares. The stock had previously closed at $27.55. Analysts Set New […]
Cheyne Capital Management UK LLP acquired a new stake in shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 18,927 shares of the company’s stock, valued at approximately $555,000. Cheyne Capital Management UK LLP owned […]